Pulmozyme Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Nebulised Dornase Alfa for Treatment of COVID-19
Conditions:   COVID19;   Hypoxia Intervention:   Drug: Dornase Alfa Inhalation Solution [Pulmozyme] Sponsor:   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With COVID19-induced ARDS (COVIDORNASE)
Conditions:   COVID-19;   Acute Respiratory Distress Syndrome Interventions:   Drug: Dornase Alfa Inhalation Solution [Pulmozyme];   Procedure: standard procedure Sponsors:   Fondation Ophtalmologique Adolphe de Rothschild;   University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2020 Category: Research Source Type: clinical trials